Trial intelligence / Profile preview

Pioglitazone for Muscle Metabolism in Obese Older Adults

NCT02305069Completed

Sponsor
University of Nottingham
Start
Oct 2009
Primary completion
Oct 2011
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial in obesity and Sarcopenia comparing Placebo with Pioglitazone (2 arms). Primary endpoint: Change in muscle protein synthesis response to simulated feeding at 12 weeks. Started Oct 2009; status: completed.

02

Drugs

pioglitazone
03

Conditions

obesitySarcopenia

Beyond the preview

Go deeper on NCT02305069.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02305069.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call